In conclusion, ABCC5 and TUBG1 are likely to become copathogenic factors of NAFLD and HCC, opening a new window of opportunity for individualized and precise diagnosis, prevention, and treatment of NAFLD. This evidence concerns the gene TUBG1 and metabolic dysfunction-associated steatotic liver disease.